Pharmaceutical Investing Ascendis Pharma Files Investigational New Drug Application for Phase 2 Trial of TransCon
Pharmaceutical Investing Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat
Pharmaceutical Investing MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) in Glioblastoma
Krystal Biotech’s KB103 Receives Orphan Medicinal Product Designation in Europe for Dystrophic Epidermolysis Bullosa
Pharmaceutical Investing Actinium Announces Submission of IND For Actimab-A in Combination with CLAG-M
Voyager Therapeutics Announces FDA Clearance of Investigational New Drug Application for Advanced Parkinson’s Disease
JZR Gold Inc. Announces Completion of Testing of Gravimetric Mill at the Vila Nova Gold Project in Brazil
China's Mineral Export Ban Reinforces Electric Royalties' Long-Term Strategic Focus on Projects Located in Safer Jurisdictions
